Maxcyte Inc (MXCT)

EBITDA Growth

30.66%

Quarterly · Period ending:

MXCT logo

MXCT EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported30.66%
MXCT Quarterly EBITDA YoY % (38.09% → 30.66%)
High-resolution chart · PNG

MXCT ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Maxcyte Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
30.66%
58.7823%
12.9036%
-6.1386%
-33.3494%
-6.7617%
-128.4483%
18.4912%
12.5659%
15.1714%
-7.6594%
-126.188%
-22.9935%
-177.1027%
12.9882%
-180.9519%
-88.8908%
40.8027%
-113.1029%
20.4228%
-58.082%
-118.586%
-34.77%
-63.9737%
40.6373%
36.4153%
17.4691%
17.4691%
-101.4655%
-101.4655%
27.9392%
27.9392%
-9.9392%
-9.9392%
-204.7049%
-204.7049%
-334.3246%
-334.3246%
-1,268.2907%
-1,268.2907%
-66.7158%
-66.7158%
59.2581%
59.2581%
38.0876%
38.0876%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.